Related Articles
Topical 5% potassium permanganate solution accelerates the healing process in chronic diabetic foot ulcers
Predictability of antitumor efficacy of cetuximab plus irinotecan based on skin rash severity according to observation period in patients with metastatic colorectal cancer following failure of fluorouracil, irinotecan and oxaliplatin
First-line cetuximab-based chemotherapies for patients with advanced or metastatic KRAS wild-type colorectal cancer
Topical vidarabine or 5-fluorouracil treatment against persistent HPV in genital (pre)cancerous lesions
Correlation between efficacy and skin rash occurrence following treatment with the epidermal growth factor receptor inhibitor cetuximab: A single institution retrospective analysis